| Zhang, Lina |
NCT06351150: Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed Shock |
|
|
| Not yet recruiting | 3 | 214 | RoW | Angiotensin II Injection, 0.9% sodium chloride injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Vasodilatory Shock | 06/27 | 12/27 | | |
NCT05707832: A Study of ABCD for Injection in Subjects With Invasive Candidiasis and Invasive Aspergillus |
|
|
| Not yet recruiting | 3 | 60 | RoW | Amphotericin B cholesteryl Sulfate Complex for Injection | CSPC Ouyi Pharmaceutical Co., Ltd. | Invasive Candidiasis, Invasive Aspergillosis | 08/25 | 12/25 | | |
SWATCH, NCT05265975: A Study of ATG-010 in Combination With Lenalidomide and Rituximab (R2) in Adults With DLBCL and iNHL |
|
|
| Recruiting | 1/2 | 84 | RoW | ATG-010, Selinexor, Lenalidomide, Rituximab | Antengene Corporation | Diffuse Large B-cell Lymphoma, Indolent Non-Hodgkin Lymphoma | 03/25 | 06/25 | | |
| Huang, Kai Ling |
SPH3127-301, NCT05359068: Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension |
|
|
| Completed | 3 | 957 | RoW | SPH3127 tablet, Valsartan | Shanghai Pharmaceuticals Holding Co., Ltd | Essential Hypertension | 12/23 | 12/23 | | |
| Terminated | 2/3 | 60 | US, RoW | NaBen®, Placebo | SyneuRx International (Taiwan) Corp | Schizophrenia | 10/23 | 10/23 | | |
NCT06322706: A Clinical Trial to Evaluate a High-Fat Meal and Omeprazole Enteric-coated Tablets on ASBK021 |
|
|
| Not yet recruiting | 1 | 36 | NA | ABSK021, Omeprazole | Abbisko Therapeutics Co, Ltd | Healthy Subjects | 12/24 | 12/25 | | |
| Deng, Shan |
| No trials found |
